MediPal Holdings Corporation (MEPDF) Stock

About MediPal Holdings Corporation

Medipal Holdings Corporation is a prominent player in Japan's prescription pharmaceutical wholesale sector. The company's core business involves the sourcing and distribution of a wide array of healthcare products. This includes medical equipment, materials, and clinical diagnostic reagents designed for use across the entire patient journey, from early detection of pre-symptomatic conditions through treatment and administration. Beyond mere distribution, Medipal also provides post-marketing surveillance (PMS) services on behalf of manufacturers and strategically invests in niche areas such as orphan drugs. Its wholesale activities are not limited to pharmaceuticals for human use. Medipal maintains a diverse product portfolio that also features over-the-counter (OTC) medications, cosmetics, and everyday household goods. Furthermore, it supplies animal health products tailored for companion animals, alongside raw materials crucial for food processing within the agriculture, fisheries, and livestock industries. The company's offerings in this segment extend to livestock feed additives, various seasonings, specialized veterinary medical equipment, packaging materials, and industrial chemicals. Complementing its extensive product range, Medipal delivers a variety of specialized services. These encompass undertaking contract-based epidemiological and clinical studies, as well as developing and managing computerized databases for medical supplies and master product data for healthcare facilities. The corporation also assists with health insurance claims reviews, provides medical coding professionals, offers outsourcing solutions, and delivers remote educational programs. Other operational facets include acting as an agent for life and non-life insurance, managing cleaning services, overseeing the operations of numerous distribution centers, facilitating commissioned delivery services, and providing worker dispatch. A key strategic endeavor involves the planning, management, administration, and product/service development for its distinctive 'class A health dispensing pharmacies' service brand. Medipal Holdings Corporation serves a vast and varied clientele. This includes medical institutions like hospitals, clinics, and dispensing pharmacies, as well as retail channels such as drugstores, home centers, convenience stores, supermarkets, and discount stores. Its reach also extends to animal hospitals, businesses in the livestock and fishery sectors, and manufacturers of processed foods. Founded in 1898, the company is headquartered in Tokyo, Japan. It rebranded to Medipal Holdings Corporation in October 2009, having previously been known as Mediceo Paltac Holdings Co., Ltd.

MediPal Holdings Corporation is headquartered in JP.

MediPal Holdings Corporation (MEPDF) stock trades at $18.35 with a market capitalization of $3.76B. The stock is valued at a price-to-earnings (P/E) ratio of 13.95, price-to-book of 0.90, price-to-sales of 0.15. Over the past 52 weeks the stock has ranged between $15.90 and $19.00, and currently trades 3.4% below its 52-week high. It pays a dividend yielding 2.29%.

On profitability, MediPal Holdings Corporation generates a return on equity (ROE) of 6.72%, return on capital employed of 6.23%, an operating margin of 1.39%, a net profit margin of 1.11%.

Official website: www.medipal.co.jp